The latest study on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global XXX Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis By Type Segment:
Immune DTaP Vaccine
Therapy DTaP Vaccine
Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis By Application Segment:
Adult
Pediatric
Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis By Regions (Countries):-
The Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Report:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market:
Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market status and future forecast.
To present the key Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Study Coverage
1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Product
1.4.2 Immune DTaP Vaccine
1.4.3 Therapy DTaP Vaccine
1.5 Market by End User
1.5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by End User
1.5.2 Adult
1.5.3 Pediatric
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size
2.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue 2016-2027
2.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2016-2027
2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Growth Rate by Regions
2.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Regions
2.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers
3.1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers
3.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Manufacturers
3.1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers
3.2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2016-2020)
3.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2016-2020)
3.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Manufacturers
3.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Product
4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Product
4.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by End User
6 North America
6.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
6.1.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
6.1.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
6.3 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
7 Europe
7.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
7.1.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
7.1.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
7.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
8.1.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
8.1.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
8.3 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
9 Central & South America
9.1 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
9.1.1 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
9.1.2 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
9.3 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
10.1.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
10.1.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
10.3 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.1.5 Sanofi Pasteur Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.2.4 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Protein Sciences Corporation
11.3.1 Protein Sciences Corporation Company Details
11.3.2 Company Business Overview
11.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.3.4 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.3.5 Protein Sciences Corporation Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Company Business Overview
11.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.4.4 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.4.5 Novartis AG Recent Development
11.5 Seqirus
11.5.1 Seqirus Company Details
11.5.2 Company Business Overview
11.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.5.4 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.5.5 Seqirus Recent Development
11.6 Merck Sharp & Dohme Corp
11.6.1 Merck Sharp & Dohme Corp Company Details
11.6.2 Company Business Overview
11.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.6.4 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.6.5 Merck Sharp & Dohme Corp Recent Development
11.7 Astellas Pharma US, Inc
11.7.1 Astellas Pharma US, Inc Company Details
11.7.2 Company Business Overview
11.7.3 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.7.4 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.7.5 Astellas Pharma US, Inc Recent Development
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Details
11.8.2 Company Business Overview
11.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.8.4 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.8.5 Pfizer Inc Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Company Business Overview
11.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.9.4 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.9.5 Johnson & Johnson Recent Development
11.10 Lanzhou Institute of Biological Products Co., Ltd
11.10.1 Lanzhou Institute of Biological Products Co., Ltd Company Details
11.10.2 Company Business Overview
11.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2019-2020)
11.10.4 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
11.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
11.11 AstraZeneca
11.12 Emergent BioSolutions Inc
12 Future Forecast
12.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Forecast by Regions
12.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2021-2027
12.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2021-2027
12.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Forecast by Product
12.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Product 2021-2027
12.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Product 2021-2027
12.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Forecast by End User
12.4 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
12.5 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
12.6 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
12.7 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
12.8 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Picture
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Segments
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Covered
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Product 2021-2027 (K Doses) & (Million US$)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Product 2016-2027
Figure Immune DTaP Vaccine Product Picture
Table Major Manufacturers of Immune DTaP Vaccine
Figure Therapy DTaP Vaccine Product Picture
Table Major Manufacturers of Therapy DTaP Vaccine
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by End User 2021-2027 (K Doses)
Figure Adult
Figure Pediatric
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Report Years Considered
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size 2016-2027 (Million US$)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2016-2027 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Regions 2016-2020 (K Doses) & (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Regions 2016-2020 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions 2016-2020
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions 2016-2020
Figure 2020 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Regions
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions 2016-2020 (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions 2016-2020
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions 2016-2020
Figure 2020 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers (2019-2020) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Manufacturers (2019-2020)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Manufacturers in 2020
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2019-2020) (Million USD)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2019-2020)
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Value Share by Manufacturers in 2020
Table Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (2016-2020) (USD/Dose)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
Table Date of International Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Product (2016-2020) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Product (2016-2020)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Product (2016-2020)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Product in 2020
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Product (2016-2020) (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Product (2016-2020)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Product (2016-2020)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Product in 2020
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Product 2016-2020 (USD/Dose)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by End User (2016-2020) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by End User (2016-2020)
Figure Global Sales Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by End User (2016-2020)
Figure Global Sales Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by End User in 2020
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2020) (K Doses)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2020)
Figure 2020 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2020) (Million US$)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2020)
Figure 2020 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (K Doses)
Figure Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Product (2016-2020) (K Doses)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Product (2016-2020)
Figure 2020 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Product
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by End User (2016-2020) (K Doses)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by End User (2016-2020)
Figure 2020 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by End User
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2020) (K Doses)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2020)
Figure 2020 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2020) (Million US$)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2020)
Figure 2020 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Product (2016-2020) (K Doses)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Product (2016-2020)
Figure 2020 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Product
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by End User (2016-2020) (K Doses)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by End User (2016-2020)
Figure 2020 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by End User
Figure Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2020) (K Doses)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2020)
Figure 2020 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2020) (Million US$)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2020)
Figure 2020 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Australia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Australia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Indonesia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Indonesia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Malaysia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Malaysia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Philippines Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Philippines Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Thailand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Thailand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Vietnam Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Vietnam Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Singapore Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Singapore Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Product (2016-2020) (K Doses)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Product (2016-2020)
Figure 2020 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Product
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by End User (2016-2020) (K Doses)
Table Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by End User (2016-2020)
Figure 2020 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by End User
Figure Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2020) (K Doses)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2020)
Figure 2020 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2020) (Million US$)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2020)
Figure 2020 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Product (2016-2020) (K Doses)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Product (2016-2020)
Figure 2020 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Product
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by End User (2016-2020) (K Doses)
Table Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by End User (2016-2020)
Figure 2020 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by End User
Figure Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate 2016-2020 (K Doses)
Figure Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2016-2020 (Million US$)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries (2016-2020) (K Doses)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries (2016-2020)
Figure 2020 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Countries
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries (2016-2020) (Million US$)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries (2016-2020)
Figure 2020 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Countries
Figure GCC Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure GCC Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure Egypt Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure Egypt Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Figure South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate (2016-2020) (K Doses)
Figure South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate (2016-2020) (Million US$)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Product (2016-2020) (K Doses)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Product (2016-2020)
Figure 2020 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Product
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by End User (2016-2020) (K Doses)
Table Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by End User (2016-2020)
Figure 2020 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by End User
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table Sanofi Pasteur Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table GlaxoSmithKline Recent Development
Table Protein Sciences Corporation Company Details
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table Protein Sciences Corporation Recent Development
Table Novartis AG Company Details
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table Novartis AG Recent Development
Table Seqirus Company Details
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table Seqirus Recent Development
Table Merck Sharp & Dohme Corp Company Details
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table Merck Sharp & Dohme Corp Recent Development
Table Astellas Pharma US, Inc Company Details
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table Astellas Pharma US, Inc Recent Development
Table Pfizer Inc Company Details
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table Pfizer Inc Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table Johnson & Johnson Recent Development
Table Lanzhou Institute of Biological Products Co., Ltd Company Details
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2020)
Table Lanzhou Institute of Biological Products Co., Ltd Recent Development
Table AstraZeneca Company Details
Table Emergent BioSolutions Inc Company Details
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2021-2027 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share Forecast by Regions 2021-2027
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2021-2027 (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share Forecast by Regions 2021-2027
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Product 2021-2027 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share Forecast by Product 2021-2027
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Product 2021-2027 (Million US$)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share Forecast by Product 2021-2027
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by End User 2021-2027 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share Forecast by End User 2021-2027
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast (2021-2027) (Million US$)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Value Chain
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers List
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources